v3.26.1
Stockholders’ Equity
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Stockholders’ Equity

Note 11 –Stockholders’ Equity

 

Equity Issuances

 

The Company completed equity transactions during the years ended December 31, 2025 and 2024. The following table provides an overview of those transactions:

  

(In thousands)

 

Date   Description  Type  Number of
Shares
   Transaction
Fees
  

Net

Proceeds

 
2025                   
November 4 through December 19   At-the-Market Offering (ATM)  Common Stock   78   $234   $782 
                       
2024                      
September 30   Confidentially Marketed Public Offering (CMPO)  Common Stock   120   $1,409   $13,591 

 

The 2025 transaction is a result of the sale the common stock under an At-the-Market Agreement (“ATM”), entered into on October 30, 2025 to create an at-the-market equity program under which the Company may sell up to $50 million of shares of its common stock from time to time. 

 

The 2024 transaction included approximately 2,000 pre-funded warrants and approximately 9,000 warrants to the underwriter with a weighted average exercise price of the warrants is $140.88 and a fair value of $1.0 million based on the Black Scholes method and the following weighted average input assumptions:

 

Contractual life  5.0 years 
Volatility   90%
Risk free interest rate   4%
Dividend yield   0.00%

 

 

Warrants

 

A summary of warrant activity is presented below:

   

    Common Stock 
    

Number of
Warrants

(In thousands)

    

Weighted

Average

Exercise

Price

    

Weighted

Average

Remaining

Life in

Years

    

Intrinsic

Value

(In thousands)

 
Outstanding, January 1, 2024   489   $227.15    3.03   $14,096 
Issued   11    111.30           
Expired   (138)   253.04           
Outstanding, December 31, 2024   362    213.92    2.80    8,505 
Exercised   (77)   -           
Expired   (22)   303.07           
Outstanding and exercisable, December 31, 2025   263   $267.78    0.92   $63